Impacts of Hydrocodone Rescheduling on Prescription Opioid Use Among Older Breast Cancer Patients
Abstract Number:
2636
Submission Type:
Contributed Abstract
Contributed Abstract Type:
Paper
Participants:
Chan Shen (1), Mohammad Ikram (1), Douglas Leslie (1), Shouhao Zhou (1), Roger Klein (2), J. Douglas Thornton (3)
Institutions:
(1) Penn State University, N/A, (2) Rutgers University, N/A, (3) University of Houston, N/A
Co-Author(s):
First Author:
Presenting Author:
Abstract Text:
Introduction: The 2014 rescheduling of hydrocodone aimed to reduce opioid misuse, but its impact on cancer patient prescriptions is under-researched. This study examines the effects of this policy change on opioid prescriptions in older breast cancer patients.
Methods: We analyzed SEER-Medicare data for female patients aged 65+ diagnosed with invasive breast cancer (2011-2018), focusing on hydrocodone and other opioid prescriptions within one year post-diagnosis. Logistic regression models were used, adjusting for demographics, clinical characteristics, and time trends.
Results: Of 79,899 patients, 45.3% received hydrocodone and 47.7% other opioids. The multivariable logistic regression showed that post-rescheduling, hydrocodone prescriptions decreased significantly (OR=0.78, p<0.001), while non-hydrocodone opioid prescriptions increased (OR=1.23, p<0.001).
Conclusion: The rescheduling led to reduced hydrocodone prescriptions among older breast cancer patients but increased non-hydrocodone opioid prescriptions, indicating a shift in prescribing patterns. This highlights the effects of policy changes on prescription behavior in oncology.
Keywords:
policy change|breast cancer|SEER-Medicare|opioid use|oncology|large observational data
Sponsors:
Health Policy Statistics Section
Tracks:
Miscellaneous
Can this be considered for alternate subtype?
No
Are you interested in volunteering to serve as a session chair?
No
I have read and understand that JSM participants must abide by the Participant Guidelines.
Yes
I understand that JSM participants must register and pay the appropriate registration fee by June 1, 2024. The registration fee is non-refundable.
I understand
You have unsaved changes.